TokenPost·

Ideaya Plans IDE849 Cohort for About 90 Patients With Neuroendocrine Cancer

Your call?

The planned single-arm extension would enroll previously treated patients with gastroenteropancreatic neuroendocrine carcinoma in an ongoing Phase 1/2 study.

Share

More news